Cervical cancer (CC) is the third most diagnosed cancer among females worldwide and the
fourth cause of cancer‑related mortality. Prophylactic HPV vaccines and traditional pap …

Human papillomaviruses (HPV) infection is a major causative agent and strongly associated
with the development of cervical cancer. Understanding the mechanisms of HPV-induced …

Cervical cancer (CC) is the primary cause of cancer deaths in underdeveloped countries.
The persistence of infection with high-risk human papillomavirus (HPV) is a significant …

Cervical cancer (CC) is one of the leading causes of death in women due to cancer and a
major concern in the developing world. Persistent human papilloma virus (HPV) infection is …

MicroRNAs (miRNAs) have become the center of interest in oncology. In recent years,
various studies have demonstrated that miRNAs regulate gene expression by influencing …

Cervical cancer (CC) is one of the most common malignancies affecting women worldwide.
While the morbidity and mortality associated with CC are decreasing in western countries …

MicroRNAs (miRNAs) are a class of small non coding RNAs of 18–25 nucleotides in length.
The temporal or short-lived expression of the miRNAs modulates gene expression post …

Cervical cancer (CC) is a common malignancy in women and a major cause of cancer‐
related mortality globally. Some novel biomarkers may enable the early diagnosis and …

Cervical carcinogenesis induced by persistent human papillomavirus (HPV) infection
represents a stepwise progression from precursors to invasive cervical cancer. Accumulated …

MicroRNAs (miRNAs) play an important role in a variety of physiological as well as
pathophysiological processes, including carcinogenesis. The aim of this study is to identify a …